<img alt="" height="1" width="1" />Ironwood and Astellas Announce Japan Licensing Agreement for LinaclotidePharmaLive.com (press release)Linaclotide is currently in Phase 3 clinical development in the United States for the treatment of irritable bowel syndrome with constipation (IBS-C) and ...<nobr></nobr> |